活动类型: 网络研讨会, 继续法律教育（CLE）或继续专业发展（CPD）
- 7 November 2022, 2:00 PM ET
- 7 November 2022, 3:00 PM ET
This presentation will discuss significant preemption-related developments over the last twelve months, both favorable and unfavorable, in product liability litigation involving prescription drugs (including generics), medical devices, vaccines, and OTC drugs. While the emphasis will be practical – using preemption to win cases in litigation – the presentation will fit new case-law into the Supreme Court's overall preemption framework.
This is Part 1 of a six-part series. Part 2, Ethics and E-Discovery: Lessons Learned from the Alex Jones Case and Others is taking place on November 8, 2022, Part 3, Current Trends in Today’s Pharma and Device Litigation is taking place on November 9, 2022, Part 4, Healthcare Fraud and Abuse in a Digital World is taking place on November 9, 2022, Part 5, Warning Causation: Taxonomy and Tactics is taking place on November 10, 2022, and Part 6, MDL Trends is taking place on November 10, 2022.
CLE Information: This webinar is presumptively approved for 1.0 CLE credit in California, Connecticut, Illinois, New Jersey, New York, Pennsylvania, Texas and West Virginia. Applications for CLE credit will be filed in Florida, Ohio, and Virginia. Attendees who are licensed in other jurisdictions will receive a uniform certificate of attendance but Reed Smith only provides credit for the states listed. Please allow 4-6 weeks after the program to receive a certificate of attendance.